4//SEC Filing
Scruggs Rick D 4
Accession 0001209191-13-015342
CIK 0001009356other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:54 PM ET
Size
6.6 KB
Accession
0001209191-13-015342
Insider Transaction Report
Form 4
Scruggs Rick D
Executive Vice President
Transactions
- Sale
Common Stock
2013-03-07$49.69/sh−2,000$99,380→ 48,566 total - Sale
Common Stock
2013-03-06$49.34/sh−5,000$246,700→ 50,566 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.32 to $49.39, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeother
Related Parties
1- filerCIK 0001520801
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 4:54 PM ET
- Size
- 6.6 KB